Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak, C Sampson-Landers, N Benda… - Contraception, 2004 - Elsevier
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …
被引用次数：157 相关文章

[引用][C] Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G BACHMANN, PJ SULAK… - Contraception …, 2004 - pascal-francis.inist.fr
Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg
ethinylestradiol and 3 mg drospirenone CNRS Inist Pascal-Francis CNRS Pascal and …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak… - Contraception …, 2004 - scholarship.libraries.rutgers.edu
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak, C Sampson-Landers… - …, 2004 - contraceptionjournal.org
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak, C Sampson-Landers, N Benda… - Contraception, 2004 - infona.pl
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak, C Sampson-Landers… - …, 2004 - researchwithrutgers.com
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.

G Bachmann, PJ Sulak, C Sampson-Landers… - …, 2004 - europepmc.org
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak… - …, 2004 - pubmed.ncbi.nlm.nih.gov
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak, C Sampson-Landers, N Benda… - Contraception, 2004 - infona.pl
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

G Bachmann, PJ Sulak… - Contraception …, 2004 - scholarship.libraries.rutgers.edu
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …